CSIMarket
 


Moderna Inc   (MRNA)
Other Ticker:  
 
 

MRNA's Revenue Growth by Quarter and Year

Moderna Inc 's Revenue results by quarter and year




MRNA Revenue (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December 2,811.00 5,084.00 7,211.00 570.75
III Quarter September 1,831.00 3,364.00 4,969.00 157.91
II Quarter June 344.00 4,749.00 4,354.00 66.35
I Quarter March 1,862.00 6,066.00 1,937.00 8.39
FY   6,848.00 19,263.00 18,471.00 803.40



MRNA Revenue fourth quarter 2023 Y/Y Growth Comment
Moderna Inc reported fall in Revenue in the fourth quarter 2023 by -44.71% to $ 2,811.00 millions, from the same quarter in 2022.
The drop in the fourth quarter 2023 Moderna Inc 's Revenue compares unfavorably to the Company's average Revenue doubling of 67255.43%.

Looking into fourth quarter 2023 results within Biotechnology & Pharmaceuticals industry 8 other companies have achieved higher Revenue growth. While Moderna Inc ' s Revenue drop of -44.71% ranks overall at the positon no. 1065 in the fourth quarter 2023.




MRNA Revenue ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December -44.71 % -29.5 % 1163.43 % 438938.46 %
III Quarter September -45.57 % -32.3 % 3046.73 % 315720 %
II Quarter June -92.76 % 9.07 % 6462.17 % 94685.71 %
I Quarter March -69.3 % 213.16 % 22987.01 % -
FY   -64.45 % 4.29 % 2199.1 % 321260 %

Financial Statements
Moderna Inc 's fourth quarter 2023 Revenue $ 2,811.00 millions MRNA's Income Statement
Moderna Inc 's fourth quarter 2022 Revenue $ 5,084.00 millions Quarterly MRNA's Income Statement
New: More MRNA's historic Revenue Growth >>


MRNA Revenue (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December 53.52 % 51.13 % 45.12 % 261.44 %
III Quarter September 432.27 % -29.16 % 14.12 % 138 %
II Quarter June -81.53 % -21.71 % 124.78 % 690.82 %
I Quarter March -63.38 % -15.88 % 239.38 % 6353.85 %
FY (Year on Year)   -64.45 % 4.29 % 2199.1 % 321260 %




Revenue fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #9
Healthcare Sector #121
Overall #1065

Revenue Y/Y Growth Statistics
High Average Low
532643.15 % 67255.43 % -64.45 %
(Sep 30 2020)   (Dec 31 2023)
Revenue fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #9
Healthcare Sector #121
Overall #1065
Revenue Y/Y Growth Statistics
High Average Low
532643.15 % 67255.43 % -64.45 %
(Sep 30 2020)   (Dec 31 2023)

Revenue by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Moderna Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
6249.58 % 369.09 % -100 %
(Mar 31 2020)  


MRNA's IV. Quarter Q/Q Revenue Comment
Moderna Inc achieved in the IV. Quarter 2023 below company average Revenue jump of 53.52% quarter on quarter, to $ 2,811.00 millions.

IV. Quarter 2023 results seem to be paradoxical, albeit beneath the average increase of 369.09 %, yet it demonstrates real improvement compare to the 51.13% in the same quarter a year ago

Within Biotechnology & Pharmaceuticals industry Moderna Inc achieved highest sequential Revenue growth. While Moderna Inc 's Revenue growth quarter on quarter, overall rank is 68.


Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #1
Healthcare Sector #7
Overall #68
Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #1
Healthcare Sector #7
Overall #68
Revenue Q/Q Growth Statistics
High Average Low
6249.58 % 369.09 % -100 %
(Mar 31 2020)  


MRNA's IV. Quarter Q/Q Revenue Comment
Moderna Inc achieved in the IV. Quarter 2023 below company average Revenue jump of 53.52% quarter on quarter, to $ 2,811.00 millions.

Albeit the IV. Quarter 2023 results were below the average of 369.09 %, this was yet good news, as the IV. Quarter improvement, transcends the 51.13% Revenue rise in the IV. Quarter 2022

Within Biotechnology & Pharmaceuticals industry Moderna Inc achieved highest sequential Revenue growth. While Moderna Inc 's Revenue growth quarter on quarter, overall rank is 68.


Moderna Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
Cumulative Revenue 12 Months Ending $ 6,848.00 $ 9,121.00 $ 10,654.00 $ 15,059.00 $ 19,263.00
Y / Y Revenue Growth (TTM) -64.45 % -57.36 % -53.67 % -33.37 % 4.29 %
Year on Year Revenue Growth Overall Ranking # 657 # 280 # 142 # 15 # 4
Seqeuential Revenue Change (TTM) -24.92 % -14.39 % -29.25 % -21.82 % -9.94 %
Seq. Revenue Growth (TTM) Overall Ranking # 2990 # 3602 # 3710 # 3574 # 2647




Cumulative Revenue growth Comment
Moderna Inc 's cumulative 12 months Revenue continue to drop, but on the faster rate at -64.45% year on year, at Dec 31 2023 compare to the -57.36% decrease at Sep 30 2023. If the Moderna Inc 's fiscal year would end at Dec 31 2023, annual Revenue would be $6,848 millions.

In the Healthcare sector 79 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 280 to 657.

Revenue TTM Q/Q Growth Statistics
High Average Low
532643.15 %
67255.43 %
-64.45 %
(Sep 30 2020)  

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 9
Healthcare Sector # 80
Overall # 657

Revenue TTM Y/Y Growth Statistics
High Average Low
532643.15 %
67255.43 %
-64.45 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 30
Sector # 318
S&P 500 # 2329
Cumulative Revenue growth Comment
Moderna Inc 's cumulative 12 months Revenue continue to drop, but on the faster rate at -64.45% year on year, at Dec 31 2023 compare to the -57.36% decrease at Sep 30 2023. If the Moderna Inc 's fiscal year would end at Dec 31 2023, annual Revenue would be $6,848 millions.

In the Healthcare sector 79 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 280 to 657.

Revenue TTM Q/Q Growth Statistics
High Average Low
532643.15 %
67255.43 %
-64.45 %
(Sep 30 2020)  


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 9
Healthcare Sector # 80
Overall # 657

Revenue TTM Y/Y Growth Statistics
High Average Low
532643.15 %
67255.43 %
-64.45 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 30
Sector # 318
S&P 500 # 2329




Other Revenue Growth
Biotechnology & Pharmaceuticals Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
MRNA's Revenue Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for MRNA's Competitors
Revenue Growth for Moderna Inc 's Suppliers
Revenue Growth for MRNA's Customers

You may also want to know
MRNA's Annual Growth Rates MRNA's Profitability Ratios MRNA's Asset Turnover Ratio MRNA's Dividend Growth
MRNA's Roe MRNA's Valuation Ratios MRNA's Financial Strength Ratios MRNA's Dividend Payout Ratio
MRNA's Roa MRNA's Inventory Turnover Ratio MRNA's Growth Rates MRNA's Dividend Comparisons



Companies with similar Revenue drop for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2023
Healthcare Services Group Inc -0.04%$ -0.042 millions
Integra Lifesciences Holdings Corp-0.25%$ -0.247 millions
National Research Corporation-0.37%$ -0.375 millions
The Beauty Health Company-0.63%$ -0.633 millions
3m Company-0.82%$ -0.817 millions
Viatris Inc -1.00%$ -0.998 millions
Aspira Women s Health Inc -1.07%$ -1.068 millions
Quest Diagnostics Inc-1.93%$ -1.929 millions
Koru Medical Systems Inc-2.16%$ -2.161 millions
Envista Holdings Corporation-2.30%$ -2.300 millions
Zynex inc -3.11%$ -3.114 millions
Shl Telemedicine Ltd-3.26%$ -3.259 millions
Baxter International Inc -3.55%$ -3.550 millions
Caribou Biosciences Inc -3.63%$ -3.629 millions
Gilead Sciences Inc -3.72%$ -3.722 millions
Lifevantage Corp-3.92%$ -3.921 millions
Avantor Inc -4.02%$ -4.022 millions
Journey Medical Corporation-4.44%$ -4.441 millions
Escalon Medical Corp -4.53%$ -4.533 millions
Inovio Pharmaceuticals Inc -4.55%$ -4.553 millions
American Shared Hospital Services-4.73%$ -4.725 millions
Optinose Inc -4.76%$ -4.756 millions
Cryoport inc -5.13%$ -5.133 millions
Psychemedics Corporation-5.24%$ -5.243 millions
Hookipa Pharma inc -5.38%$ -5.378 millions
Abbvie inc -5.42%$ -5.423 millions
Hologic Inc-5.69%$ -5.688 millions
Medicure Inc -5.94%$ -5.944 millions
Encision Inc -6.08%$ -6.083 millions
Biogen Inc -6.20%$ -6.199 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com